19 June 2013
Keywords: valera, completes, ph, iii, supprelin, la, study
Article | 17 April 2006
The USA's Valera Pharmaceuticals says it has successfully completed the active clinical portion of a Phase III study of Supprelin ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com